AppointmentsEuro Cannabis Leader Alfredo Pascual To Join UK Investor...

Euro Cannabis Leader Alfredo Pascual To Join UK Investor With £12m-Plus To Deploy

-

UK investment fund Fast Forward Innovations has added Alfredo Pascual – one of Europe’s leading cannabis industry figures – to its team, as it looks to close in on a further two deals in short order.

Mr Pascual rose to prominence during his spell as German-based International Analyst at the US cannabis conference and news publishing outfit Marijuana Business Daily (MJBizDaily).

Speaking to BusinessCann he said he was excited by the opportunities that lie ahead with Fast Forward (FFWD) as its new Vice President of Investment Analysis.

“After spending recent years analysing the complex European cannabis industry, I am excited to now work with FastForward to find and assess companies which are well positioned to capitalise on the opportunities being presented in the sector, and which are potential investment opportunities for FastForward,” he said.

Invaluable Knowledge

Ed McDermott, Chief Executive Officer of FFWD, said: “I am delighted to welcome Alfredo to our team; his experience and sector knowledge will be invaluable to FFWD’s shareholders as our investment focus increasingly leans towards health, wellness and medical cannabis.” 

FFWD is the only European quoted investment fund with a stated focus on the cannabis space and features a portfolio of leading companies including; Northern Leaf, Yooma, South West Brands and Little Green Pharma.

It recently secured an additional £5m in funds following the sale of EMMAC Life Sciences to leading US cannabis player Curaleaf. EMMAC was co-founded by Mr McDermot and FFWD had a 2.3% stake .

FFWD says this exit cash brings it total investment pot to over £12m with Mr McDermott telling BusinessCann its expects to see ‘additional liquidity from legacy portfolio assets over the coming months’.

Deals Imminent

Adding: “The likelihood is that we will have a larger cash position to invest, than is currently stated, over the coming months.”

He also went on to say that it expects to boost its investee portfolio to ‘at least six, in the very short term’.

In his new role Mr Pascual will focus on sourcing and evaluating investment opportunities in the European medical cannabis industry as well as supporting the growth of FFWD’s portfolio companies in the sector.

Uruguay-born Mr Pascual moved to Germany to study and whilst undertaking a Masters in Public Policy, in 2016, he became ‘fascinated’ by drug policy. 

Before joining MJBizDaily in 2018 he worked in international business development roles for different companies in the sector.

Looking ahead Mr Pascual believes his in-depth knowledge of the European cannabis space and its businesses will prove invaluable.

“The European cannabis markets could be huge, but at this early stage it’s not easy to identify the companies that will be the market leaders of tomorrow. 

“That’s where my network of contacts across Europe and knowledge of the different markets and regulations becomes useful.”

Cannabis Ancillaries

As well as medical cannabis, hemp and CBD, FFWD is also seeking opportunities in supporting ancillary services.

He continued: “As a sector with an essentially uncapped upside but where companies need to find ways to unlock that potential, that means not simply producing medical cannabis or having a CBD brand. It means finding competitive advantages. 

“We could be the investors that provide capital to the leading companies of tomorrow. But not just that. We can also offer them a unique combined expertise that includes things such as a clear path to liquidity, regulatory and market expertise, and a unique network to help expand the business.

“At this early stage, all segments have plenty of potential. More than the specific segment within the cannabis industry where a company operates, we care about what it is doing to unleash its potential.”

FFWD is an AIM-listed investment company focused primarily on disruptive, high-growth life sciences and technology businesses, as well as medical cannabis arena. 

The company’s strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where sufficient time and resource can be devoted. 


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Germany’s ‘KanaVape’ Moment As Police And Courts Crackdown On ‘Narcotic’ Hemp & CBD

TWO senior figures in the European cannabis industry are leading the fight against over-zealous German law enforcement in a...

UK CBD Consumption To Switch From Oils To Capsules – As New Research Estimates Market Value At £690m

CAPSULES are set to replace oils as the preferred method of CBD consumption - as new research show the...

Crowdfunding: An Emerging Capital Greenhouse For The Cannabis Industry

ALPHAGREEN is expected to hit close to the £2m crowdfunding mark on the Seedrs platform by mid-May – double...

Former JP Morgan Banker Lands Two UK Cannabis Jobs

A VETRAN of American investment bank JP Morgan has entered the burgeoning field of cannabis with appointments to two...

Europe’s Hemp Pioneer Posts Record Results With CBD, Construction And Car-Making To The Fore

EUROPEAN pioneer HempFlax has posted record annual results with revenues up 43% to €14.5m (£12.5m) as it returned a...

Sales Up Sharply At Sativa Wellness But Operational Costs Lead to £4.5m Loss

BRITISH CBD firm Sativa Wellness saw annual sales rise by over one-third in an eventful year which saw it...

Must read

Germany’s ‘KanaVape’ Moment As Police And Courts Crackdown On ‘Narcotic’ Hemp & CBD

TWO senior figures in the European cannabis industry are...

You might also likeRELATED
Recommended to you